financetom
Business
financetom
/
Business
/
Rush Street Interactive Insider Sold Shares Worth $1,944,759, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rush Street Interactive Insider Sold Shares Worth $1,944,759, According to a Recent SEC Filing
Mar 12, 2025 12:54 AM

03:25 AM EDT, 03/12/2025 (MT Newswires) -- Richard Todd Schwartz, Director, Chief Executive Officer, on March 10, 2025, sold 193,905 shares in Rush Street Interactive ( RSI ) for $1,944,759. Following the Form 4 filing with the SEC, Schwartz has control over a total of 1,998,038 Class A common shares of the company, with 1,998,038 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1793659/000179365925000053/xslF345X05/wk-form4_1741730821.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Telegram's Durov: I am back in Dubai
Telegram's Durov: I am back in Dubai
Mar 17, 2025
MOSCOW (Reuters) - Pavel Durov, the Russian-born founder and CEO of Telegram, said on Monday that he had returned to Dubai. Durov was arrested at an airport near Paris last August and subsequently placed under formal investigation, with a ban on leaving France. Durov said he had spent several months in France due to an investigation related to the activity...
DuPont names insider Jon Kemp as CEO of electronics business post spin-off
DuPont names insider Jon Kemp as CEO of electronics business post spin-off
Mar 17, 2025
March 17 (Reuters) - Chemical firm DuPont De Nemours ( DD ) said on Monday insider Jon Kemp will take over as chief executive officer of its independent electronics unit, which will be created following its intended spin-off. ...
AstraZeneca Seals Deal For EsoBiotec To Advance Cell Therapy: Details
AstraZeneca Seals Deal For EsoBiotec To Advance Cell Therapy: Details
Mar 17, 2025
EsoBiotec SA, a biotechnology company specializing in in vivo cell therapies, has announced a definitive agreement to be acquired by AstraZeneca ( AZN ) PLC . The agreement represents a major step forward for EsoBiotec, which has demonstrated encouraging early clinical results with its Engineered NanoBody Lentiviral (ENaBL) platform. AstraZeneca ( AZN ) is acquiring all of EsoBiotec’s outstanding equity...
Willow Biosciences to Sell Subsidiary for US$3.4 Million
Willow Biosciences to Sell Subsidiary for US$3.4 Million
Mar 17, 2025
06:53 AM EDT, 03/17/2025 (MT Newswires) -- Willow Biosciences ( CANSF ) late on Friday said is agreed to sell its operating subsidiary Epimeron USA, including the biotechnology business, intellectual property and research and development team, to a U.K.-based privately-held, arms-length entity for US$3.4 million in cash. The transaction, which Willow's strategic review, is scheduled to close on or about...
Copyright 2023-2026 - www.financetom.com All Rights Reserved